Site-directed in vitro immunization leads to a complete human monoclonal IgG4λ that binds specifically to the CDR2 region of CTLA-4 (CD152) without interfering the engagement of natural ligands
Tóm tắt
The ability to acquire fully human monoclonal antibodies (mAbs) with pre-defined specificities is critical to the development of molecular tags for the analysis of receptor function in addition to promising immunotherapeutics. Yet most of the arriving affinity maturated and complete human immunoglobulin G (IgG) molecules, which are actually derived from single human B cells, have not widely been used to study the conserved self antigens (Ags) such as CD152 (cytotoxic T lymphocyte antigen-4, CTLA-4) because proper hosts are lacking. Here we developed an optimized protocol for site-directed in vitro immunizing peripheral blood mononuclear cells (PBMC) by using a selected epitope of human CD152, an essential receptor involved in down-regulation of T cell activation. The resultant stable trioma cell lines constantly produce anti-CD152 mAb (γ4λhuCD152), which contains variable (V) regions of the heavy chain and the light chain derived from the VH3 and Vλ human germline genes, respectively, and yet displays an unusual IgG4 isotype. Interestingly, γ4λhuCD152 has a basic pI not commonly found in myeloid monoclonal IgG4λs as revealed by the isoelectric focusing (IEF) analysis. Furthermore, γ4λhuCD152 binds specifically, with nanomolar affinity, to an extracellular constituency encompassing the putative second complementarity determining region (CDR2) of CD152, whereby it can react to activated CD3+ cells. In a context of specific cell depletion and conditioned medium,in vitro induction of human Abs against a conserved self Ag was successfully acquired and a relatively basic mAb, γ4λhuCD152, with high affinity to CDR2 of CD152 was thus obtained. Application of such a human IgG4λ mAb with designated CDR2 specificity may impact upon and prefer for CD152 labeling both in situ and ex situ, as it does not affect the binding of endogenous B7 ligands and can localize into the confined immunological synapse which may otherwise prevent the access of whole IgG1 molecules.
Tài liệu tham khảo
Winter G, Griffiths AD, Hawkins RE, Hoogenboom HR: Making antibodies by phage display technology. Annu Rev Immunol. 1994, 12: 433-455. 10.1146/annurev.iy.12.040194.002245.
Kretzschmar T, von Rüden T: Antibody discovery: phage display. Curr Opin Biotechnol. 2002, 13: 598-602. 10.1016/S0958-1669(02)00380-4.
Kellermann SA, Green LL: Antibody discovery: the use of transgenic mice to generate human monoclonal antibodies for therapeutics. Curr Opin Biotechnol. 2002, 13: 593-597. 10.1016/S0958-1669(02)00354-3.
Magadán S, Valladares M, Suarez E, Sanjuán I, Molina A, Ayling C, Davies SL, Zou X, Williams GT, Neuberger MS, Brüggemann M, Gambón F, Diíz-Espada F, González-Fernández A: Production of antigen-specific human monoclonal antibodies: comparison of mice carrying IgH/kappa or IgH/kappa/lambda transloci. Biotechniques. 2002, 33: 680-690.
Chin LT, Hinkula J, Levi M, Ohlin M, Wahren B, Borrebaeck CA: Site-directed primary in vitro immunization: Production of HIV-1 neutralizing human monoclonal antibodies from sero-negative donors. Immunology. 1994, 81: 428-434.
Chin LT, Malmborg AC, Kristensson K, Hinkula J, Wahren B, Borrebaeck CA: Mimicking the humoral immune response in vitro results in antigen-specific isotype switching by autologous T helper cells. Eur J Immunol. 1995, 25: 657-663. 10.1002/eji.1830250305.
Dueñas M, Chin LT, Malmborg AC, Casalvilla R, Ohlin M, Borrebaeck CA: In vitro immunization of naive human B cells yields high affinity immunoglobulin G as illustrated by phage display. Immunology. 1996, 89: 1-7. 10.1046/j.1365-2567.1996.d01-708.x.
Zafiropoulos A, Andersson E, Krambovitis E, Borrebaeck CA: Induction of antigen-specific isotype switching by in vitro immunization of human naive B lymphocytes. J Immunol Methods. 1997, 200: 181-190. 10.1016/S0022-1759(96)00207-4.
Sharpe AH, Freeman GJ: The B7-CD28 superfamily. Nat Rev Immunol. 2002, 2: 116-126. 10.1038/nri727.
Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, Ledbetter JA: CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med. 1991, 174: 561-569. 10.1084/jem.174.3.561.
Krummel MF, Allison JP: CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med. 1996, 183: 2533-2540. 10.1084/jem.183.6.2533.
Greene JL, Leytze GM, Emswiler J, Peach R, Bajorath J, Cosand W, Linsley PS: Covalent dimerization of CD28/CTLA-4 and oligomerization of CD80/CD86 regulate T cell costimulatory interactions. J Biol Chem. 1996, 271: 26762-26771. 10.1074/jbc.271.43.26762.
van der Merwe PA, Bodian DL, Daenke S, Linsley P, Davis SJ: CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics. J Exp Med. 1997, 185: 393-404. 10.1084/jem.185.3.393.
Carreno BM, Bennett F, Chau TA, Ling V, Luxenberg D, Jussif J, Baroja ML, Madrenas J: CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression. J Immunol. 2000, 165: 1352-1356.
Chai JG, Vendetti S, Amofah E, Dyson J, Lechler R: CD152 ligation by CD80 on T cells is required for the induction of unresponsiveness by costimulation-deficient antigen presentation. J Immunol. 2000, 165: 3037-3042.
Vanasek TL, Khoruts A, Zell T, Mueller DL: Antagonistic roles for CTLA-4 and the mammalian target of rapamycin in the regulation of clonal anergy: enhanced cell cycle progression promotes recall antigen responsiveness. J Immunol. 2001, 167: 5636-5644.
Schwartz JC, Zhang X, Fedorov AA, Nathenson SG, Almo SC: Structural basis for co-stimulation by the human CTLA-4/B7-2 complex. Nature. 2001, 410: 604-608. 10.1038/35069112.
Stamper CC, Zhang Y, Tobin JF, Erbe DV, Ikemizu S, Davis SJ, Stahl ML, Seehra J, Somers WS, Mosyak L: Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses. Nature. 2001, 410: 608-611. 10.1038/35069118.
Schwartz JC, Zhang X, Nathenson SG, Almo SC: Structural mechanisms of costimulation. Nat Immunol. 2002, 3: 427-434. 10.1038/ni0502-427.
Peach RJ, Bajorath J, Brady W, Leytze G, Greene J, Naemura J, Linsley PS: Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1. J Exp Med. 1994, 180: 2049-2058. 10.1084/jem.180.6.2049.
Madrenas J, Chau LA, Teft WA, Wu PW, Jussif J, Kasaian M, Carreno BM, Ling V: Conversion of CTLA-4 from inhibitor to activator of T cells with a bispecific tandem single-chain Fv ligand. J Immunol. 2004, 172: 5948-5956.
Chin LT, Cheng JY, Lu SC, Chang CHA, Chu CH, Meng CL: Establishment and evaluation of mouse-human heteromyeloma cell lines obtained by electrofusion for immortalizing human immunoglobulins. J Biomed Lab Sci. 2001, 13: 117-123.
Ohlin M, Danielsson L, Carlsson R, Borrebaeck CA: The effect of leucyl-leucine methyl ester on proliferation and Ig secretion of EBV-transformed human B lymphocytes. Immunology. 1989, 66: 485-490.
Nakamura Y, Myers BD: Charge selectivity of proteinuria in diabetic glomerulopathy. Diabetes. 1988, 9: 1202-1211. 10.2337/diabetes.37.9.1202.
Steiner K, Waase I, Rau T, Dietrich M, Fleischer B, Broker BM: Enhanced expression of CTLA-4 (CD152) on CD4+ T cells in HIV infection. Clin Exp Immunol. 1999, 115: 451-457. 10.1046/j.1365-2249.1999.00806.x.
Pistillo MP, Tazzari PL, Ellis JH, Ferrara GB: Molecular characterization and applications of recombinant scFv antibodies to CD152 co-stimulatory molecule. Tissue Antigens. 2000, 55: 229-238. 10.1034/j.1399-0039.2000.550306.x.
Gribben JG, Freeman GJ, Boussiotis VA, Rennert P, Jellis CL, Greenfield E, Barber M, Restivo VA, Ke X, Gray GS, Nadler LM: CTLA4 mediates antigen-specific apoptosis of human T cells. Proc Natl Acad Sci USA. 1995, 92: 811-815. 10.1073/pnas.92.3.811.
Aalberse RC, Schuurman J: IgG4 breaking the rules. Immunology. 2002, 105: 9-19. 10.1046/j.0019-2805.2001.01341.x.
Grakoui A, Bromley SK, Sumen C, Davis MM, Shaw AS, Allen PM, Dustin ML: The immunological synapse: a molecular machine controlling T cell activation. Science. 1999, 285: 221-227. 10.1126/science.285.5425.221.
Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G: Ex vivo isolation and characterization of CD4+CD25+ T cells with regulatory properties from human blood. J Exp Med. 2001, 193: 1303-1310. 10.1084/jem.193.11.1303.